Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers-Reference-Cited by-同舟云学术

Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers

Published:2023-01-11 Issue:4 Volume:37 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clinical Transplantation

Author:

Reininger Kevin A.¹^ORCID,Onyeaghala Guillaume²³^ORCID,Anderson‐Haag Teresa¹^ORCID,Schladt David S.²^ORCID,Wu Baolin⁴^ORCID,Guan Weihua⁴^ORCID,Dorr Casey R.²³^ORCID,Remmel Rory P.⁵^ORCID,Mannon Roslyn⁶^ORCID,Matas Arthur J.⁷^ORCID,Oetting William S.⁸^ORCID,Stahler Paul⁹^ORCID,Israni Ajay K.³¹⁰^ORCID,Jacobson Pamala A.⁸^ORCID

Affiliation:

1. Department of Pharmacy Hennepin County Medical Center Minneapolis Minnesota USA

2. Hennepin Healthcare Research Institute Minneapolis Minnesota USA

3. Division of Nephrology Hennepin Healthcare University of Minnesota Minneapolis Minnesota USA

4. Department of Biostatistics University of Minnesota Minneapolis Minnesota USA

5. Department of Medicinal Chemistry University of Minnesota Minneapolis Minnesota USA

6. Division of Nephrology University of Nebraska Omaha Nebraska USA

7. Department of Surgery University of Minnesota Minneapolis Minnesota USA

8. Department of Experimental and Clinical Pharmacology University of Minnesota Minneapolis Minnesota USA

9. Division of Surgery Hennepin Healthcare Minneapolis Minnesota USA

10. Department of Epidemiology and Community Health University of Minnesota Minneapolis Minnesota USA

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14893

Reference36 articles.

1. High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime

2. Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection

3. A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation

4. Higher Variability of Tacrolimus Trough Level Increases Risk of Acute Rejection in Kidney Transplant Recipients

5. Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of CYP3A5 genotype-guided tacrolimus dosing in solid organ transplantation using real-world data;The Pharmacogenomics Journal;2024-05-15

2. Optimizing the initial tacrolimus dosage in Chinese children with lung transplantation within normal hematocrit levels;Frontiers in Pediatrics;2024-01-31

3. Tacrolimus pharmacokinetics are influenced by CYP3A5, age, and concomitant fluconazole in pediatric kidney transplant patients;Clinical and Translational Science;2023-06-26

4. CYP3A5 Polymorphism in Renal Transplantation: A Key to Personalized Immunosuppression;Transplantation Proceedings;2023-06